Biomarker Diagnostics

Biomarker Diagnostics for Neurodegenerative Disease

Two female researchers in a laboratory Scottish Brain Sciences provides high-quality biomarker testing services to support the early detection and diagnosis of Alzheimer’s disease and other neurodegenerative conditions.

Our UKAS ISO 15189-accredited laboratory delivers robust, clinically reliable data to pharmaceutical, biotech and academic partners—supporting clinical trials, translational research and the development of next-generation diagnostics.

Get in touch to discuss how we can support your biomarker strategy or study commercial@brainsciences.scot

Our capabilities

Image shows blood samples in test tubes.

We offer a comprehensive range of biomarker services, including:

Plasma and CSF biomarker analysis
pTau-181 and pTau-217 assays
Sample processing and biobanking
Support for clinical trial biomarker strategies
Data generation for translational and observational studies

Our laboratory works with well-characterised cohorts and established protocols to ensure consistency, reproducibility and scientific rigour.

Leadership in Biomarkers

Accredited quality
ISO 15189 accreditation ensures the highest standards in laboratory processes, data integrity and clinical reliability

Advanced biomarker expertise
Capability in blood- and cerebrospinal fluid (CSF)-based assays, including pTau-181 and pTau-217

Clinical and research integration
Supporting both clinical trials and the transition to real-world diagnostic applications

Proven industry collaboration
Trusted by leading pharmaceutical partners, including Roche and Eli Lilly

Scalable and reliable delivery
Generating high-quality data across studies, cohorts and multi-site programmes

UKAS Accreditation Symbol - white on purple - Medical

Supporting clinical trials and diagnostics

Biomarkers are transforming how neurodegenerative diseases are detected, stratified and treated.

We work with partners across the development pathway to:

Enable earlier and more accurate detection of Alzheimer’s disease
Support patient stratification and trial recruitment
Generate reliable biomarker endpoints
Advance the development of diagnostic tools

Explore biomarker solutions. Contact our team today.

Send an email